The Baylor University Medical Center at Dallas and the Baylor Scott & White Research Institute unveiled that a baby girl had been born after a uterus transplant clinical trial, in a case of absolute uterine factor infertility. This birth is the result of an altruistic transplant from a living donor, in which neither the donor nor the recipient knows the identity of the other person. The Baylor Medical Center has already performed a total of 20 uterus transplants, making it the largest program of its kind in the world.
An article about the project of Baylor University Medical Center in Dallas was published on September 2019 in which has bioethical implications (see HERE our approach on this relevant topic).
In the article, Giuliano Testa, principal investigator of the clinical trial, comments that he feels honored to have helped deliver the baby and is very satisfied with the selfless act of the uterine donor thanks to which the pregnancy could occur.
Option for women with absolute uterine factor infertility
According to Liza Johannesson, a gynecologic surgeon and medical director at Baylor University Medical Center, each delivery is further evidence that uterine transplantation is a viable option for women with absolute uterine factor infertility.
Baylor University Medical Center is among the first in the US to explore uterine transplantation, which is being studied as a new infertility treatment option for women with absolute uterine factor infertility. This is that your uterus does not work or does not exist.
The team led by researcher Giuliano Testa has performed a total of 20 uterus transplants, making it the largest program of its kind in the world.
Baylor University Medical Center attributes the success of this clinical trial to a multidisciplinary team of physicians, nurses, and researchers from various specialties, including transplantation, gynecology, obstetrics, maternal-fetal medicine, and psychology.
The medical team has more than 35 years of experience helping women have babies while taking immunosuppressive medications after an organ transplant.
Supported by the Baylor Scott & White Research Institute, this innovative program is committed to advancing science for the benefit of the medical community in general and women living with uterine factor infertility in particular.
Philanthropic support for this groundbreaking clinical trial was provided by the Baylor Scott & White Foundation. That Foundation is seeking additional funding to continue the research, which could potentially benefit other women with absolute uterine infertility through this pioneering procedure.
Bioethical assessment of the uterus transplant
Uterus transplantation is a promising pioneering technique to treat female infertility, but its application presents objective bioethical problems.